Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.
Saved in:
| Title: | Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. |
|---|---|
| Authors: | Zhao B; Department of Pathology, Feinberg School of Medicine, and.; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Mei Y; Department of Pathology, Feinberg School of Medicine, and.; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Cao L; Department of Pathology, Feinberg School of Medicine, and.; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China., Zhang J; Department of Pathology, Feinberg School of Medicine, and.; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Sumagin R; Department of Pathology, Feinberg School of Medicine, and.; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Yang J; Department of Pathology, Feinberg School of Medicine, and.; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Gao J; Department of Pathology, Feinberg School of Medicine, and.; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Schipma MJ; Center for Genetic Medicine, Northwestern University, Chicago, Illinois, USA., Wang Y; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Zhongnan Hospital of Wuhan University, Wuhan, China., Thorsheim C; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Zhao L; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Stalker T; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Stein B; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.; Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois, USA., Wen QJ; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.; Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois, USA., Crispino JD; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.; Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois, USA., Abrams CS; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ji P; Department of Pathology, Feinberg School of Medicine, and.; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2018 Jan 02; Vol. 128 (1), pp. 125-140. Date of Electronic Publication: 2017 Nov 20. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
